BBI LIFE SCIENCES CORPORATION Inactive Instrument
BBI Life Sciences Corporation Stock
Equities
1035
KYG1089Y1180
Biotechnology & Medical Research
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Luo Jia Wang
CEO | Chief Executive Officer | 55 | - |
Xiao Lei Gu
DFI | Director of Finance/CFO | 43 | 15-09-10 |
Jin Wang
PSD | President | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qi Song Wang
CHM | Chairman | 83 | - |
Jian Jun Liu
BRD | Director/Board Member | 56 | 14-01-15 |
Luo Jia Wang
CEO | Chief Executive Officer | 55 | - |
BBI Life Sciences Corporation is an investment holding company principally engaged in the development, manufacture and sales of various life science products used in scientific research, and the provision of life science related services. These products and services offered by the Company is used in the studies of life sciences including animal and plant, disease, medical diagnosis, drug development, food and agriculture industry. The Company has four business segments: deoxyribonucleic acid (DNA) synthesis products, genetic engineering services, life science research consumables as well as protein and antibody related products and services. The principal markets of the Company include the People's Republic of China (the PRC), North America, South America, Europe and Africa.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.02% | 41.35B | |
| +42.15% | 40.38B | |
| +1.13% | 39.05B | |
| -14.19% | 26.67B | |
| +1.56% | 24.07B | |
| -24.63% | 18.36B | |
| -4.11% | 11.68B | |
| +20.72% | 11.6B | |
| +7.79% | 11.15B |
